Information Provided By: 
Fly News Breaks for March 3, 2020
XRAY
Mar 3, 2020 | 09:45 EDT
Barrington analyst Michael Petusky lowered the firm's price target on Dentsply Sirona to $60 from $63 and keeps an Outperform rating on the shares. While Dentsply is largely executing against its strategic goals, the coronavirus issue will likely dampen investor sentiment for companies with material business in the Asia Pacific region, Petusky tells investors in a research note. The analyst, however, continues to believe that Dentsply Sirona is well positioned to achieve continued margin expansion with revenue growth over the next few years.
News For XRAY From the Last 2 Days
There are no results for your query XRAY
